Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo

Syberg, S; Brandao-Burch, A; Patel, J J; Hajjawi, M; Arnett, T R; Schwarz, P; Jorgensen, N R; Orriss, I R

doi:10.1002/jbmr.1690

Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo

Syberg, S; Brandao-Burch, A; Patel, J J; Hajjawi, M; Arnett, T R; Schwarz, P; Jorgensen, N R; Orriss, I R

Authors

S Syberg

A Brandao-Burch

J J Patel

M Hajjawi

T R Arnett

P Schwarz

N R Jorgensen

I R Orriss

Citation

Syberg, S., Brandao-Burch, A., Patel, J. J., Hajjawi, M., Arnett, T. R., Schwarz, P., Jorgensen, N. R., & Orriss, I. R. Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo. Journal of Bone and Mineral Research, 27(11), 2373-86. https://doi.org/10.1002/jbmr.1690

Journal Article Type	Article
Deposit Date	Nov 12, 2014
Journal	JOURNAL OF BONE AND MINERAL RESEARCH
Print ISSN	0884-0431
Electronic ISSN	1523-4681
Publisher	Wiley
Volume	27
Issue	11
Pages	2373-86
DOI	https://doi.org/10.1002/jbmr.1690
Public URL	https://rvc-repository.worktribe.com/output/1416468

Pathological calcification in canine tendon-derived cells is modulated by extracellular ATP (2024)
Journal Article

Stable Sulforaphane Targets the Early Stages of Osteoclast Formation to Engender a Lasting Functional Blockade of Osteoclastogenesis (2024)
Journal Article

A machine learning-based image segmentation method to quantify in vitro osteoclast culture endpoints (2023)
Journal Article

Evidence that pyrophosphate acts as an extracellular signalling molecule to exert direct functional effects on primary osteoblasts and osteoclasts (2023)
Journal Article

Editorial: Special issue on purinergic signalling and calcification (2023)
Journal Article

Downloadable Citations

HTML

BIB

RTF

Authors

Citation

You might also like

Downloadable Citations